期刊文献+

ADAMTS-4与TAK1在骨关节炎软骨组织中表达的相关性研究 被引量:5

The correlative study on the expression of ADAMTS-4 and TAK1 in osteoarthritic cartilage tissue
下载PDF
导出
摘要 目的探讨带有血小板凝血酶敏感蛋白样模体的解整链蛋白金属蛋白酶-4(ADAMTS-4)与转化生长因子β激活激酶1(TAK1)在骨关节炎(OA)软骨组织中的相关性表达。方法采用病例对照研究,分别利用免疫组织化学法和Western blot法检测ADAMTS-4、TAK1在OA组及正常对照组软骨组织中的表达情况,同时研究二者在OA中表达的相关性。结果 ADAMTS-4和TAK1在OA组表达均明显高于正常对照组(P<0.01);二者在OA软骨组织中的表达呈正相关(r=0.469,P<0.05)。结论 ADAMTS-4与OA软骨病变的发生发展密切相关,活化的TAK1可能致OA软骨组织中ADAMTS-4的高表达。TAK1可以作为OA治疗的新靶点。 Objective To investigate the correlative expression of a disintegrin and metalloproteinase with throm-bospondin motif-4 ( ADAMTS-4 ) and TGF-activated kinase 1 ( TAK1 ) in the cartilage tissue of patients with osteo-arthritis ( OA) . Methods The case-control study, immunohistochemistry and Western blot were used to detect the expression of ADAMTS-4 and TAK1 in cartilage tissue of patients with OA and normal control group, and the ex-pressive correlation between ADAMTS-4 and TAK1 in OA was also analyzed. Results Both the expression of AD-AMTS-4 and TAK1 in OA group were significantly increased than that in normal control group ( P〈0.01 ); there was a positive correlation between the expression of ADAMTS-4 and TAK1 in OA cartilage tissue ( r=0 . 469 , P〈0.05) . Conclusion ADAMTS-4 is closely related to the occurrence and progress of OA cartilage. The activated TAK1 may cause the overexpression of ADAMTS-4 in OA cartilage tissue, which can be a new target for OA treat-ment.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第3期343-346,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81173075)
关键词 骨关节炎 软骨组织 ADAMTS-4 TAK1 osteoarthritis cartilage tissue ADAMTS-4 TAK1
  • 相关文献

参考文献14

  • 1Martel-Pelletier J, Boileau C, Pelletier J P, et al. Cartilage in normal and osteoarthritis conditions [J].. Best Pract Res Clin Rheumatol, 2008, 22(2) :351 -84.
  • 2Naito S, Shiomi T, Okada A, et al. Expression of ADAMTS4 (aggrecanas-I) in human osteoarthritic cartilage [J].. Pathol Int, 2007, 57( 11) :703 -II.
  • 3Berenbaum F. Signaling transduction: target in osteoarthritis [J]. . Curr OpinRheum, 2004, 16(5) :616 -22.
  • 4Johnson G L, Lapadat R. Mitogen-activated protein kinase pathways mediaed by ERK, JNK, and p38 protein kinases [J]. Science, 2002, 298(5600) :1911 -2.
  • 5Takaishi H, Kimura T, Dalal S, et al. Joint diseases and matrix metallopro teinases . a role for MMP-13[J]. Curr Pharm Biotech, 2008,9(1) :47 -54.
  • 6Verma P, Dalal K. ADAMTS4 and ADAMTS-5: key enzymes in osteoarthritis [J].. Cell Biochem, 2011, 112( 12) :3507 -14.
  • 7Yatabe T, Mochizuki S, Takizawa M, et al. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-I) in human osteoarthritic chondrocytes [J]. Ann Rheum Dis, 2009, 68 ( 6) : 1051 - 8.
  • 8Charles J M. Anticytokine therapy for osteoarthritis [J].. Drug Aging, 2010,27(2) :95 -115.
  • 9Lea M G, Jennifer H J, Loiselle A E, et al. TAKI regulate's cartilage and joint development via the MAPK and BMP signaling pathways [J].. J Bone Miner Res, 2010, 25(8) :1784 -97.
  • 10Sondergaard B C, Schultz N, Madsen S H, et al. MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation-divergence in pathways leading to aggrecanase and MMPmediated articular cartilage degradation [J].. Osteoarthritis Cartilage, 2010,18(3) :279 -88.

同被引文献63

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部